Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(4.05)
# 526
Out of 5,090 analysts
387
Total ratings
43.56%
Success rate
14.86%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASMB Assembly Biosciences | Assumes: Buy | $50 | $35.01 | +42.82% | 1 | Aug 18, 2025 | |
| ALT Altimmune | Reiterates: Buy | $12 | $5.24 | +129.01% | 19 | Aug 13, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $500 → $570 | $458.12 | +24.42% | 27 | Aug 7, 2025 | |
| CMPS COMPASS Pathways | Maintains: Buy | $45 → $40 | $5.82 | +587.29% | 17 | Aug 4, 2025 | |
| ATAI Atai Beckley | Maintains: Buy | $10 → $15 | $4.32 | +247.22% | 20 | Jul 30, 2025 | |
| ANRO Alto Neuroscience | Reiterates: Buy | $10 | $13.43 | -25.54% | 2 | Jun 26, 2025 | |
| IVVD Invivyd | Reiterates: Buy | $5 | $2.23 | +124.22% | 19 | Jun 26, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.50 | +1,916.54% | 26 | Jun 24, 2025 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $6.96 | +977.59% | 24 | Jun 13, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $38.78 | +157.86% | 21 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $21.33 | +228.18% | 15 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.99 | +403.98% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $5.02 | +1,095.22% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $61.44 | +30.21% | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $14.89 | +168.64% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $4.28 | +600.93% | 10 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $39.83 | +75.75% | 6 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $27.09 | +195.31% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $10 | $2.68 | +273.13% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.33 | +200.30% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $12.35 | +345.34% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $6.50 | +1,592.31% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $80.50 | +5.59% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $150 | $5.99 | +2,404.17% | 17 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $13.58 | +400.74% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $156.94 | +116.64% | 1 | Aug 18, 2021 |
Assembly Biosciences
Aug 18, 2025
Assumes: Buy
Price Target: $50
Current: $35.01
Upside: +42.82%
Altimmune
Aug 13, 2025
Reiterates: Buy
Price Target: $12
Current: $5.24
Upside: +129.01%
Alnylam Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $500 → $570
Current: $458.12
Upside: +24.42%
COMPASS Pathways
Aug 4, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $5.82
Upside: +587.29%
Atai Beckley
Jul 30, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $4.32
Upside: +247.22%
Alto Neuroscience
Jun 26, 2025
Reiterates: Buy
Price Target: $10
Current: $13.43
Upside: -25.54%
Invivyd
Jun 26, 2025
Reiterates: Buy
Price Target: $5
Current: $2.23
Upside: +124.22%
Sangamo Therapeutics
Jun 24, 2025
Reiterates: Buy
Price Target: $10
Current: $0.50
Upside: +1,916.54%
Silence Therapeutics
Jun 13, 2025
Reiterates: Buy
Price Target: $75
Current: $6.96
Upside: +977.59%
Immunocore Holdings
Jun 2, 2025
Reiterates: Buy
Price Target: $100
Current: $38.78
Upside: +157.86%
May 29, 2025
Reiterates: Buy
Price Target: $70
Current: $21.33
Upside: +228.18%
May 21, 2025
Reiterates: Buy
Price Target: $5
Current: $0.99
Upside: +403.98%
May 21, 2025
Reiterates: Buy
Price Target: $60
Current: $5.02
Upside: +1,095.22%
May 20, 2025
Reiterates: Buy
Price Target: $80
Current: $61.44
Upside: +30.21%
May 9, 2025
Reiterates: Buy
Price Target: $40
Current: $14.89
Upside: +168.64%
Apr 8, 2025
Reiterates: Buy
Price Target: $30
Current: $4.28
Upside: +600.93%
Apr 8, 2025
Reiterates: Buy
Price Target: $70
Current: $39.83
Upside: +75.75%
Apr 7, 2025
Reiterates: Buy
Price Target: $80
Current: $27.09
Upside: +195.31%
Apr 1, 2025
Maintains: Buy
Price Target: $25 → $10
Current: $2.68
Upside: +273.13%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $3.33
Upside: +200.30%
Mar 7, 2025
Reiterates: Buy
Price Target: $55
Current: $12.35
Upside: +345.34%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $6.50
Upside: +1,592.31%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $80.50
Upside: +5.59%
Feb 13, 2025
Maintains: Buy
Price Target: $190 → $150
Current: $5.99
Upside: +2,404.17%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $13.58
Upside: +400.74%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $156.94
Upside: +116.64%